BERTARINI, LAURA
BERTARINI, LAURA
A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol
2024 Brighenti, V.; Marani, M.; Caroli, C.; Bertarini, L.; Gaggiotti, A.; Pollastro, F.; Durante, C.; Cannazza, G.; Pellati, F.
Broad spectrum metallo beta-lactamases inhibitors: New tools against clinically-relevant carbapenemases
2022 Lazzarato, L.; Failla, M.; Gianquinto, E.; Bersani, M.; Bertarini, L.; Verri, A.; Vascon, F.; Sannio, F.; Verdirosa, F.; Beatrice, N.; De Luca, F.; Costi, Mp.; Cruciani, G.; Docquier, Jd.; Cendron, L.; Spyrakis, F.; Tondi, D.
Drug Discovery and preclinical Development for Human and Animal African Trypanosomiasis: Profiling of a collection of Natural Compounds with ADME-(Eco)Toxicity properties
2024 Bertarini, Laura; Pellati, Federica; Costi, Maria Paola
ECOTOXICOLOGICAL PROFILING AND LEADS PRIORITIZATION THROUGH MACHINE LEARNING-BASED APPROACH FOR THE DESIGN OF SAFER ANTIPARASITIC AGENTS
2025 Aiello, Daniele; Bertarini, Laura; Gul, Sheraz; Pellati, Federica; Costi, Maria Paola
Fighting Antibiotic Resistance • Drug Repurposing and Structure-Based Optimization of Benzoxaboroles as LexA Inhibitors
2025 Tondi, Donatella; Martinelli, Ilenia; Bellio, Pierangelo; Bertarini, Laura; Vascon, Filippo; Nazzicone, Lisaurora; Fagnani, Lorenza; Severini, Andrea; Lezza, Antonio; Cendron Giuseppe Celenza &, Laura; Roncaglia, Fabrizio
Identifying lipid patterns through lipidomic profiling for MASLD detection and severity stratification
2025 Bertarini, Laura; Gabrielli, Filippo; Nascimbeni, Fabio; Andreone, Pietro; Pellati, Federica
In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body
2024 Tiburtini, G. A.; Bertarini, L.; Bersani, M.; Dragani, T. A.; Rolando, B.; Binello, A.; Barge, A.; Spyrakis, F.
Lichen secondary metabolites as potential inhibitors of viral 3-chymotrypsin-like protease (3CLpro)
2024 Fagnani, Lorenza; Bellio, Pierangelo; Nazzicone, Lisaurora; Franceschini, Nicola; Tondi, Donatella; Bertarini, Laura; Giuseppe Celenza, And
Lipidomic profiling of MASLD: identifying lipid biomarkers for detection and stratification of disease severity
2025 Bertarini, Laura; Gabrielli, Filippo; Nascimbeni, Fabio; Andreone, Pietro; Pellati, Federica
Looking for broad-spectrum inhibitors targeting carbapenemases
2022 Spyrakis, Francesca; Gianquinto, Eleonora; Bersani, M.; Failla, M.; Bertarini, Laura; Vascon, Filippo; Sannio, F.; Verdirosa, F.; Beatrice, N.; De, Luca; N., Costi; Maria, Paola.; Cruciani, G.; Docquier, J-D; Cendron, Laura.; Tondi, Donatella; Lazzarato, L.
Mapping the lipid landscape of MASLD: insights into disease progression through lipidomic patterns
2025 Bertarini, Laura; Gabrielli, Filippo; Nascimbeni, Fabio; Andreone, Pietro; Pellati, Federica
Mechanism of non-competitive inhibition of the SARS-CoV-2 3CL protease dimerization: Therapeutic and clinical promise of the lichen secondary metabolite perlatolinic acid
2024 Fagnani, L.; Bellio, P.; Di Giulio, A.; Nazzicone, L.; Iorio, R.; Petricca, S.; Franceschini, N.; Bertarini, L.; Tondi, D.; Celenza, G.
Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria
2023 Bersani, M.; Failla, M.; Vascon, F.; Gianquinto, E.; Bertarini, L.; Baroni, M.; Cruciani, G.; Verdirosa, F.; Sannio, F.; Docquier, J. D.; Cendron, L.; Spyrakis, F.; Lazzarato, L.; Tondi, D.
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer
2024 Pippione, Agnese Chiara; Kovachka, Sandra; Vigato, Chiara; Bertarini, Laura; Mannella, Iole; Sainas, Stefano; Rolando, Barbara; Denasio, Enrica; Piercy-Mycock, Helen; Romalho, Linda; Salladini, Edoardo; Adinolfi, Salvatore; Zonari, Daniele; Peraldo-Neia, Caterina; Chiorino, Giovanna; Passoni, Alice; Mirza, Osman Asghar; Frydenvang, Karla; Pors, Klaus; Lolli, Marco Lucio; Spyrakis, Francesca; Oliaro-Bosso, Simonetta; Boschi, Donatella
Targeted metabolomics for the analysis of p-cresol in mouse brain by HPLC-ESI-MS/MS
2024 Bertarini, Laura; Imbeni, Federico; Liao, Wenjie; Piemontese, Monica; Vilella, Antonietta; Alboni, Silvia; Pellati, Federica
Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS
2024 Bertarini, Laura; Imbeni, Federico; Liao, Wenjie; Piemontese, Monica; Vilella, Antonietta; Alboni, Silvia; Pellati, Federica
Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS: a new tool for drug discovery
2024 Bertarini, Laura; Imbeni, Federico; Alboni, Silvia; Pellati, Federica
Targeted Metabolomics for the Analysis of p-Cresol in Mouse Brain: Impact of Biological Sex and Strain
2025 Bertarini, L.; Imbeni, F.; Vilella, A.; Alboni, S.; Pellati, F.
Targeting the Transcriptional Repressor LexA to Overcome Bacterial Resistance A Strategy Based on Drug Repurposing and Lead Optimization
2025 Tondi, Donatella; Martinelli, Ilenia; Lezza, Antonio; Severini, Andrea; Bertarini, Laura; Vascon, Filippo; Cendron, Laura; Nazzicone, Lisaurora; Fagnani, Lorenza; Bellio, Pierangelo; Roncaglia, Fabrizio; Celenza, Giuseppe
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents
2024 Linciano, Pasquale; Pozzi, Cecilia; Tassone, Giusy; Landi, Giacomo; Mangani, Stefano; Santucci, Matteo; Luciani, Rosaria; Ferrari, Stefania; Santarem, Nuno; Tagliazucchi, Lorenzo; Cordeiro-da-Silva, Anabela; Tonelli, Michele; Tondi, Donatella; Bertarini, Laura; Gul, Sheraz; Witt, Gesa; Moraes, Carolina B; Costantino, Luca; Costi, Maria Paola
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol | 1-gen-2024 | Brighenti, V.; Marani, M.; Caroli, C.; Bertarini, L.; Gaggiotti, A.; Pollastro, F.; Durante, C.; Cannazza, G.; Pellati, F. | |
| Broad spectrum metallo beta-lactamases inhibitors: New tools against clinically-relevant carbapenemases | 1-gen-2022 | Lazzarato, L.; Failla, M.; Gianquinto, E.; Bersani, M.; Bertarini, L.; Verri, A.; Vascon, F.; Sannio, F.; Verdirosa, F.; Beatrice, N.; De Luca, F.; Costi, Mp.; Cruciani, G.; Docquier, Jd.; Cendron, L.; Spyrakis, F.; Tondi, D. | |
| Drug Discovery and preclinical Development for Human and Animal African Trypanosomiasis: Profiling of a collection of Natural Compounds with ADME-(Eco)Toxicity properties | 1-gen-2024 | Bertarini, Laura; Pellati, Federica; Costi, Maria Paola | |
| ECOTOXICOLOGICAL PROFILING AND LEADS PRIORITIZATION THROUGH MACHINE LEARNING-BASED APPROACH FOR THE DESIGN OF SAFER ANTIPARASITIC AGENTS | 1-gen-2025 | Aiello, Daniele; Bertarini, Laura; Gul, Sheraz; Pellati, Federica; Costi, Maria Paola | |
| Fighting Antibiotic Resistance • Drug Repurposing and Structure-Based Optimization of Benzoxaboroles as LexA Inhibitors | 1-gen-2025 | Tondi, Donatella; Martinelli, Ilenia; Bellio, Pierangelo; Bertarini, Laura; Vascon, Filippo; Nazzicone, Lisaurora; Fagnani, Lorenza; Severini, Andrea; Lezza, Antonio; Cendron Giuseppe Celenza &, Laura; Roncaglia, Fabrizio | |
| Identifying lipid patterns through lipidomic profiling for MASLD detection and severity stratification | 1-gen-2025 | Bertarini, Laura; Gabrielli, Filippo; Nascimbeni, Fabio; Andreone, Pietro; Pellati, Federica | |
| In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body | 1-gen-2024 | Tiburtini, G. A.; Bertarini, L.; Bersani, M.; Dragani, T. A.; Rolando, B.; Binello, A.; Barge, A.; Spyrakis, F. | |
| Lichen secondary metabolites as potential inhibitors of viral 3-chymotrypsin-like protease (3CLpro) | 1-gen-2024 | Fagnani, Lorenza; Bellio, Pierangelo; Nazzicone, Lisaurora; Franceschini, Nicola; Tondi, Donatella; Bertarini, Laura; Giuseppe Celenza, And | |
| Lipidomic profiling of MASLD: identifying lipid biomarkers for detection and stratification of disease severity | 1-gen-2025 | Bertarini, Laura; Gabrielli, Filippo; Nascimbeni, Fabio; Andreone, Pietro; Pellati, Federica | |
| Looking for broad-spectrum inhibitors targeting carbapenemases | 1-gen-2022 | Spyrakis, Francesca; Gianquinto, Eleonora; Bersani, M.; Failla, M.; Bertarini, Laura; Vascon, Filippo; Sannio, F.; Verdirosa, F.; Beatrice, N.; De, Luca; N., Costi; Maria, Paola.; Cruciani, G.; Docquier, J-D; Cendron, Laura.; Tondi, Donatella; Lazzarato, L. | |
| Mapping the lipid landscape of MASLD: insights into disease progression through lipidomic patterns | 1-gen-2025 | Bertarini, Laura; Gabrielli, Filippo; Nascimbeni, Fabio; Andreone, Pietro; Pellati, Federica | |
| Mechanism of non-competitive inhibition of the SARS-CoV-2 3CL protease dimerization: Therapeutic and clinical promise of the lichen secondary metabolite perlatolinic acid | 1-gen-2024 | Fagnani, L.; Bellio, P.; Di Giulio, A.; Nazzicone, L.; Iorio, R.; Petricca, S.; Franceschini, N.; Bertarini, L.; Tondi, D.; Celenza, G. | |
| Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria | 1-gen-2023 | Bersani, M.; Failla, M.; Vascon, F.; Gianquinto, E.; Bertarini, L.; Baroni, M.; Cruciani, G.; Verdirosa, F.; Sannio, F.; Docquier, J. D.; Cendron, L.; Spyrakis, F.; Lazzarato, L.; Tondi, D. | |
| Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer | 1-gen-2024 | Pippione, Agnese Chiara; Kovachka, Sandra; Vigato, Chiara; Bertarini, Laura; Mannella, Iole; Sainas, Stefano; Rolando, Barbara; Denasio, Enrica; Piercy-Mycock, Helen; Romalho, Linda; Salladini, Edoardo; Adinolfi, Salvatore; Zonari, Daniele; Peraldo-Neia, Caterina; Chiorino, Giovanna; Passoni, Alice; Mirza, Osman Asghar; Frydenvang, Karla; Pors, Klaus; Lolli, Marco Lucio; Spyrakis, Francesca; Oliaro-Bosso, Simonetta; Boschi, Donatella | |
| Targeted metabolomics for the analysis of p-cresol in mouse brain by HPLC-ESI-MS/MS | 1-gen-2024 | Bertarini, Laura; Imbeni, Federico; Liao, Wenjie; Piemontese, Monica; Vilella, Antonietta; Alboni, Silvia; Pellati, Federica | |
| Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS | 1-gen-2024 | Bertarini, Laura; Imbeni, Federico; Liao, Wenjie; Piemontese, Monica; Vilella, Antonietta; Alboni, Silvia; Pellati, Federica | |
| Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS: a new tool for drug discovery | 1-gen-2024 | Bertarini, Laura; Imbeni, Federico; Alboni, Silvia; Pellati, Federica | |
| Targeted Metabolomics for the Analysis of p-Cresol in Mouse Brain: Impact of Biological Sex and Strain | 1-gen-2025 | Bertarini, L.; Imbeni, F.; Vilella, A.; Alboni, S.; Pellati, F. | |
| Targeting the Transcriptional Repressor LexA to Overcome Bacterial Resistance A Strategy Based on Drug Repurposing and Lead Optimization | 1-gen-2025 | Tondi, Donatella; Martinelli, Ilenia; Lezza, Antonio; Severini, Andrea; Bertarini, Laura; Vascon, Filippo; Cendron, Laura; Nazzicone, Lisaurora; Fagnani, Lorenza; Bellio, Pierangelo; Roncaglia, Fabrizio; Celenza, Giuseppe | |
| The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents | 1-gen-2024 | Linciano, Pasquale; Pozzi, Cecilia; Tassone, Giusy; Landi, Giacomo; Mangani, Stefano; Santucci, Matteo; Luciani, Rosaria; Ferrari, Stefania; Santarem, Nuno; Tagliazucchi, Lorenzo; Cordeiro-da-Silva, Anabela; Tonelli, Michele; Tondi, Donatella; Bertarini, Laura; Gul, Sheraz; Witt, Gesa; Moraes, Carolina B; Costantino, Luca; Costi, Maria Paola |
